Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy

Published:2024-08 Issue:8 Volume:26 Page:832-841
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Cheng Hai,Sun Yingjun,Zhang Xiaoxue,Chen Zihan,Shao Lingyan,Liu Jiaying,Wang Dandan,Chen Yegan,Wang Xue,Chen Wei,Sang Wei,Qi Kunming,Li Zhenyu,Sun Cai,Shi Ming,Qiao Jianlin,Wu Qingyun,Zeng Lingyu,Zheng Junnian,Xu Kailin,Cao Jiang^ORCID

Funder

Jiangsu Provincial Key Research and Development Program

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference43 articles.

1. Recent advances in T-cell immunotherapy for haematological malignancies;Rouce;Br J Haematol,2017

2. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma;Garfall;JCI Insight,2018

3. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma;Raje;N Engl J Med,2019

4. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma;Brudno;J Clin Oncol,2018

5. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N Engl J Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP